Epizyme_May_2017_859_9859
Loading viewer...
investor_presentation
Format: PDF investor_presentation
This document provides an update on Epizyme's molecularly defined solid tumor program and highlights the development of tazemetostat, an innovative cancer treatment.
Related tags
More from Epizyme
View all →
Similar investor_presentations from other companies
Browse all →Lindsay Corporation Investor Presentation — January 2022
investor_presentationinvestor_presentation
12 Pages
Lindsay Corporation
investor_presentation
Lynas Corporation
